QuickView for PDE4B;jsessionid=16BA33D194091596FBEEAE45E78F7A6A;jsessionid=90DCF064E1860A91131E148457A57364;jsessionid=EC086339B348377E859BB97F0A04DEA8;jsessionid=5E81B97939C8259E557215823DD60BBB;jsessionid=8CA315E1AB039381F539A2CA87AD0FBE;jsessionid=D108422C46E296E528A758B8F9720D00;jsessionid=2441872C2DED3465DFBC0ADD4A7771F7;jsessionid=E209901101A911B0D70524E8A8B779E5 (gene)

1. Selective PDE4B and PDE4D inhibitors produce distinct behavioral responses to ethanol and GABAergic …
2. Selective Inhibition of PDE4B Reduces Binge Drinking in Two C57BL/6 Substrains.
3. Selective Inhibition of PDE4B Reduces Methamphetamine Reinforcement in Two C57BL/6 Substrains.
4. MiR-124-3p targeting PDE4B attenuates LPS-induced ALI through the TLR4/NF-κB signaling pathway.
5. LncRNA GAS5 Knockdown Mitigates Hepatic Lipid Accumulation via Regulating MiR-26a-5p/PDE4B to Activa…

There were no clinical trials for PDE4B;jsessionid=16BA33D194091596FBEEAE45E78F7A6A;jsessionid=90DCF064E1860A91131E148457A57364;jsessionid=EC086339B348377E859BB97F0A04DEA8;jsessionid=5E81B97939C8259E557215823DD60BBB;jsessionid=8CA315E1AB039381F539A2CA87AD0FBE;jsessionid=D108422C46E296E528A758B8F9720D00;jsessionid=2441872C2DED3465DFBC0ADD4A7771F7;jsessionid=E209901101A911B0D70524E8A8B779E5